| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Daniel Horwood last filed a Form 4 in November 2020, as General Counsel at VTAK. Daniel Horwood's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 21,896 shares of VTAK. Net of sales, the VTAK filings show accumulation of 20,000 shares.
Daniel Horwood has 7 Form 4 filings on record from November 2018 to November 2020, all as General Counsel at Catheter Precision (VTAK), 2018–2020.
The 8 reported transactions were 4 stock awards, 3 open-market purchases and 1 option or other derivative award.
Counted by filing, the open-market trades come to 2 purchases worth about $8K and no sales.
The largest open-market purchase was 10,000 shares of VTAK at an average $0.47 on May 22, 2020, about $5K.
Shares as reported in the last Form 4 for each company; the most recent is from November 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.